Literature DB >> 24411650

Increasing value and reducing waste: addressing inaccessible research.

An-Wen Chan1, Fujian Song2, Andrew Vickers3, Tom Jefferson4, Kay Dickersin5, Peter C Gøtzsche6, Harlan M Krumholz7, Davina Ghersi8, H Bart van der Worp9.   

Abstract

The methods and results of health research are documented in study protocols, full study reports (detailing all analyses), journal reports, and participant-level datasets. However, protocols, full study reports, and participant-level datasets are rarely available, and journal reports are available for only half of all studies and are plagued by selective reporting of methods and results. Furthermore, information provided in study protocols and reports varies in quality and is often incomplete. When full information about studies is inaccessible, billions of dollars in investment are wasted, bias is introduced, and research and care of patients are detrimentally affected. To help to improve this situation at a systemic level, three main actions are warranted. First, academic institutions and funders should reward investigators who fully disseminate their research protocols, reports, and participant-level datasets. Second, standards for the content of protocols and full study reports and for data sharing practices should be rigorously developed and adopted for all types of health research. Finally, journals, funders, sponsors, research ethics committees, regulators, and legislators should endorse and enforce policies supporting study registration and wide availability of journal reports, full study reports, and participant-level datasets.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24411650      PMCID: PMC4533904          DOI: 10.1016/S0140-6736(13)62296-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  101 in total

1.  Data sharing in medical research: an empirical investigation.

Authors:  D D Reidpath; P A Allotey
Journal:  Bioethics       Date:  2001-04       Impact factor: 1.898

2.  Data extraction errors in meta-analyses that use standardized mean differences.

Authors:  Peter C Gøtzsche; Asbjørn Hróbjartsson; Katja Maric; Britta Tendal
Journal:  JAMA       Date:  2007-07-25       Impact factor: 56.272

3.  Why are so many epidemiology associations inflated or wrong? Does poorly conducted animal research suggest implausible hypotheses?

Authors:  Michael B Bracken
Journal:  Ann Epidemiol       Date:  2009-03       Impact factor: 3.797

4.  How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing.

Authors:  I Chalmers; D G Altman
Journal:  Lancet       Date:  1999-02-06       Impact factor: 79.321

5.  The value of statistical analysis plans in observational research: defining high-quality research from the start.

Authors:  Laine Thomas; Eric D Peterson
Journal:  JAMA       Date:  2012-08-22       Impact factor: 56.272

6.  The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed.

Authors:  Sally Hopewell; Susan Dutton; Ly-Mee Yu; An-Wen Chan; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

7.  Reducing waste from incomplete or unusable reports of biomedical research.

Authors:  Paul Glasziou; Douglas G Altman; Patrick Bossuyt; Isabelle Boutron; Mike Clarke; Steven Julious; Susan Michie; David Moher; Elizabeth Wager
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

8.  The imperative to share clinical study reports: recommendations from the Tamiflu experience.

Authors:  Peter Doshi; Tom Jefferson; Chris Del Mar
Journal:  PLoS Med       Date:  2012-04-10       Impact factor: 11.069

9.  Open clinical trial data for all? A view from regulators.

Authors:  Hans-Georg Eichler; Eric Abadie; Alasdair Breckenridge; Hubert Leufkens; Guido Rasi
Journal:  PLoS Med       Date:  2012-04-10       Impact factor: 11.069

10.  Why we need easy access to all data from all clinical trials and how to accomplish it.

Authors:  Peter C Gøtzsche
Journal:  Trials       Date:  2011-11-23       Impact factor: 2.279

View more
  256 in total

1.  Are manufacturers sharing data as promised?

Authors:  Evan Mayo-Wilson; Peter Doshi; Kay Dickersin
Journal:  BMJ       Date:  2015-09-25

2.  North American regulatory agencies can and should make clinical trial data publicly available.

Authors:  Nav Persaud; Peter Doshi
Journal:  CMAJ       Date:  2015-10-13       Impact factor: 8.262

Review 3.  The evolution in registration of clinical trials: a chronicle of the historical calls and current initiatives promoting transparency.

Authors:  Claudia Pansieri; Chiara Pandolfini; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2015-08-05       Impact factor: 2.953

4.  Increasing disparities between resource inputs and outcomes, as measured by certain health deliverables, in biomedical research.

Authors:  Anthony Bowen; Arturo Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

5.  Routinely collected data and comparative effectiveness evidence: promises and limitations.

Authors:  Lars G Hemkens; Despina G Contopoulos-Ioannidis; John P A Ioannidis
Journal:  CMAJ       Date:  2016-02-16       Impact factor: 8.262

6.  If nothing happens, is everything all right? Distinguishing genuine reassurance from a false sense of security.

Authors:  Yoon Kong Loke; Katharina Mattishent
Journal:  CMAJ       Date:  2014-11-17       Impact factor: 8.262

7.  The limits of research.

Authors:  Delan Devakumar; Sílvia R Shikanai Yasuda; Shailen Sutaria
Journal:  J R Soc Med       Date:  2015-03-31       Impact factor: 5.344

8.  Otology Jubilee: 150 years of the Archiv für Ohrenheilkunde "Where do we come from?--Where are we?--Where are we going?".

Authors:  Stefan K Plontke
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-18       Impact factor: 2.503

9.  Evaluation of Journal Registration Policies and Prospective Registration of Randomized Clinical Trials of Nonregulated Health Care Interventions.

Authors:  Marleine Azar; Kira E Riehm; Nazanin Saadat; Tatiana Sanchez; Matthew Chiovitti; Lin Qi; Danielle B Rice; Brooke Levis; Claire Fedoruk; Alexander W Levis; Lorie A Kloda; Jonathan Kimmelman; Andrea Benedetti; Brett D Thombs
Journal:  JAMA Intern Med       Date:  2019-05-01       Impact factor: 21.873

10.  Open Access Journals in Ophthalmology and Vision Science: All That Glitters Is Not Gold.

Authors:  Jimmy T Le; Riaz Qureshi; Tianjing Li
Journal:  Ophthalmology       Date:  2018-08-21       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.